Metastasis Directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-Resistant Prostate Cancer

被引:0
|
作者
Deek, M. P. [1 ]
Taparra, K. [2 ]
Phillips, R. [1 ]
Velho, P. Isaacsson [1 ]
Gao, R. W. [3 ]
Deville, C., Jr. [1 ]
Song, D. [4 ]
Greco, S. C. [4 ]
Carducci, M. [1 ]
Eisenberger, M. [1 ]
DeWeese, T. L. [4 ]
Denmeade, S. [1 ]
Pienta, K. [5 ]
Paller, C. [1 ]
Antonarakis, E. S. [1 ]
Olivier, K. [6 ]
Park, S. S. [6 ]
Tran, P. T. [4 ]
Stish, B. J. [6 ]
机构
[1] Johns Hopkins Med, Baltimore, MD USA
[2] Mayo Clin, Alix Sch Med, Rochester, MN USA
[3] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[4] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
[5] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA
[6] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4079
引用
收藏
页码:E893 / E894
页数:2
相关论文
共 50 条
  • [31] Current Status of Castration-Resistant Prostate Cancer Drug Therapy
    Mao, Yifeng
    Hu, Mingqiu
    Yang, Gaowei
    Gao, Erke
    Chen, Wenbang
    INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY, 2021, 6 (01): : 41 - 49
  • [32] Current, new and novel therapy for castration-resistant prostate cancer
    Gaya, Josep M.
    Ahallal, Youness
    Sanchez-Salas, Rafael
    Barret, Eric
    Rozet, Francois
    Macek, Marc Galiano Peter
    Durand, Matthieu
    Cerruti, Jennifer
    Prapotnich, Dominique
    Ropert, Stanislas
    Bennamoun, Mostefa
    Cathelineau, Xavier
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (07) : 819 - 827
  • [33] Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer
    Sausan Abouharb
    Paul G. Corn
    Current Oncology Reports, 2013, 15 : 217 - 223
  • [34] Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer
    Agarwal, Neeraj
    Sonpavde, Guru
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2012, 61 (05) : 950 - 960
  • [35] Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer
    Abouharb, Sausan
    Corn, Paul G.
    CURRENT ONCOLOGY REPORTS, 2013, 15 (03) : 217 - 223
  • [36] Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer
    Hwang, Clara
    Henderson, Nicholas C.
    Chu, Shih-Chun
    Holland, Brandon
    Cackowski, Frank C.
    Pilling, Amanda
    Jang, Albert
    Rothstein, Shoshana
    Labriola, Matthew
    Park, Joseph J.
    Ghose, Alyssa
    Bilen, Mehmet A.
    Mustafa, Seema
    Kilari, Deepak
    Pierro, Michael J.
    Thapa, Bicky
    Tripathi, Abhishek
    Garje, Rohan
    Ravindra, Aditya
    Koshkin, Vadim S.
    Hernandez, Erik
    Schweizer, Michael T.
    Armstrong, Andrew J.
    Mckay, Rana R.
    Dorff, Tanya B.
    Alva, Ajjai S.
    Barata, Pedro C.
    JAMA NETWORK OPEN, 2023, 6 (09) : e2334208
  • [37] Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy
    Armandari, Inna
    Hamid, Agus Rizal
    Verhaegh, Gerald
    Schalken, Jack
    PROSTATE INTERNATIONAL, 2014, 2 (03) : 105 - 113
  • [38] The changing landscape of hormonal therapy in castration-resistant prostate cancer
    Dongre, Amol
    Prabhash, Kumar
    Noronha, Vanita
    SOUTH ASIAN JOURNAL OF CANCER, 2012, 1 (02) : 53 - 55
  • [39] Castration-Resistant Prostate Cancer-Hormone Therapy Redux
    Tolcher, Anthony W.
    Cooper, Josh
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1447 - 1449
  • [40] Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer
    Mendiratta, Prateek
    Mostaghel, Elahe
    Guinney, Justin
    Tewari, Alok K.
    Porrello, Alessandro
    Barry, William T.
    Nelson, Peter S.
    Febbo, Phillip G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2022 - 2029